Developing an Effective Service for Enuretic Children in UNRWA’s Health Centeres by خلدون محمد حسين زيد & Khaldoon Mohammad Husein Zaid
Deanship of Graduate Studies 
Al Quds University 
  
 
 
 
 
 
Developing an Effective Service for Enuretic Children in 
UNRWA’s Health Centeres 
 
 
 
 
Khaldoon Mohammad Husein Zaid 
 
 
M.Sc. Thesis 
 
 
 
  
ii 
 
Jerusalem-Palestine 
 
1436/2015 
Developing an Effective Service for Enuretic Children in 
UNRWA’s Health Centers 
 
 
 
Prepared By 
Khaldoon Mohammad Husein Zaid 
 
 
 
B.Sc.  
University of Pharmacy & Medicine “Iuliu Hatieganu” 
Romania 
 
Supervisors 
Dr. Douglas Simkiss & Luma Tarazi, M.Sc. 
 
 
  
iii 
 
Thesis Submitted in Partial Fulfillment of the 
Requirements for the Degree of Master of Science Arts at 
Al-Quds University. 
1436/2015 
Al Quds University 
Deanship of Graduate Studies 
Child Health / Faculty of Medicine  
 
Thesis Approval 
 
Developing an Effective Service for Enuretic Children  
in UNRWA Health Centers 
 
 
Prepared By: Khaldoon Mohammad Husein Zaid 
Registration No: 
 
Supervisors 
Dr. Douglas Simkiss & Luma Tarazi, M.Sc. 
 
Master thesis submitted and accepted, Date………… 
The names and signatures of the examiners committee are as 
follow 
  
iv 
 
1. Head of the Committee                                         Signature 
2. Internal Examiner                                                 Signature 
 
Jerusalem-Palestine 
1436 / 2015 
 
Dedication 
 
 
To all children in my country who are suffering from nocturnal enuresis. 
Hoping that this study, as a small contribution, will be to help them to enjoy 
life  
 
 
 
 
 
 
 
 
 
 
  
v 
 
 
 
 
 
 
Declaration 
 
I Certify that this thesis submitted for the degree of Master is a result of my 
own research, except where otherwise acknowledged, and that this study (or 
any part of the same) has not been submitted for a higher degree to any 
university or institution.   
 
 
Signed  
 
Khaldoon Mohammad Husein Zaid 
 
Date: February 20, 2015 
 
 
 
  
vi 
 
 
 
  
  
vii 
 
 
 
Acknowledgements 
 
First of all I’d like to thank my family for their moral support which was crucial 
for me to finish this adventure successfully. 
Also, many thanks to UNRWA, Health Program leadership in West Bank, for 
their support and encouragement.  
 I’d like to mention Dr. Umaiyeh Khamash, Dr. Mohammad Khalili, Dr. Adnan 
Qarmash, Dr. Bassam Daour and all may colleagues, medical officers and 
social counselors, for their help and support.  
Gratitude to all my tutors from UK and Palestine who worked hard with us so 
we can become more efficient in delivering and promoting better health 
services that our people deserve. 
Thanks to my friend Dr. Waleed Sweileh for his advices and support.  
And, my recognition and gratitude to our beloved mentor Dr. Samir Khalil for 
his commitment to this program and his continuous and unlimited support.  
I’d like to thank Al Quds University and the Dean of the Faculty of Medicine 
Dr. Hani Abdeen for their support to make this program possible here in 
Palestine. 
And, not in the last instance, I cannot forget the efforts and sacrifices that had 
been made by my beloved parents, God have mercy on their souls, to give me 
the best possible education. 
  
viii 
 
 
 
 
Abstract 
Purpose  
 The purpose of this study is to find out the barriers that families and patients face while 
trying to manage their enuretic children in our health centers.  
Method  
This study was designed as a qualitative descriptive cross – sectional study.  There were two 
parts to the questionnaire, section I and section II. Section I, directed to the parents, was a 
structured questionnaire aiming to collect demographic data. Section II; open-ended 
questions were used to determine if there were barriers that parents and their children faced. 
Interviews with social workers from the eight medical centers that were involved in the study 
were performed. In addition, two elementary schools, boys and girls from Qalqilia belonging 
to UNRWA, were visited and, separated interviews with every social worker were 
performed. Interviews with Medical Officers working within UNRWA medical centers were 
performed also, to explore if they are adopting and using any local technical instruction or 
other national or international guidelines. 
 Forty questionnaires were distributed in eight northern medical centers in West bank, 5 
questionnaires for every center. The first five families of an enuretic child were offered the 
questionnaire in each health center.  
Data analysis & Results 
The total number of children with PMNE included in the study was 37 aged between 7- 12 
years old; the modal age was 7-8 years old. Of the total number of studied children 20 
(54.1%) were males while 17 (45.9%) were females. The ratio male to female is 1.2: 1 
The majority (64.9%) were from refugee camps and 29.7% from cities. This is a normal 
finding due to the fact that seven of the eight health centers studied, are situated inside the 
camps. 
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The number of families’ members varies 83.8% 4-8 members. For the educational level of 
the parents, 20.3% have university degree, 37.8% finished high school and 41.9% didn’t 
finish high school. Approximately 29.7% described their socio-economic status as good, 
43.2% as middle and 27% as poor. 
The relationship between the child and his family was found; positive in 64.9% tense; 18.9% 
weak; 16.2%. Physical punishment was used in 21.6% of the children. 
Positive family history of nocturnal enuresis was common, the percentage was 
83.8%.Children’s attitude was 24.3% careless, 67.6% shy or sad and 8.1% angry, 40.5% 
humiliated, insulted or bullied. 
Children’s reasons to overcome bedwetting;  32.4% to avoid humiliation, 24.3% to be equal 
with his peers, 16.2% to build self-confidence, 10.8% to participate in school activities and, 
16.2% had more than one reason. 
When caregivers were asked if they attend UNRWA health centers to seek help in resolving 
their enuretic children problem, 18.9% declare no, reasons for not attending our health 
centers, lack of awareness, time and family problems were evoked. 
Treatment satisfaction was found in 76.7% while 10% were not satisfied and 13.3% could 
not tell. Reasons for dissatisfaction were; lack of improvement, absence of drug treatment 
and doctors’ opinion that the child will “outgrow of the condition”.   
Approximately 35% of cases included in the study stopped attending the clinics due to 
different causes lack of time, treatment failure, family problems and father refusal were the 
most evoked causes. 
. Conclusions  
Lack of awareness, time and information, treatment failure, father refusal and family 
problems constituted the main barriers faced by families while trying to treat their enuretic 
children. In addition, absence of technical instructions, guidelines, and diagnostic and 
management algorithms made the treatment less effective. 
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Chapter I 
Nocturnal Enuresis  
1.1 Introduction 
Because of its deep impact, bedwetting constitute a very distressful problem for the child 
and the family, many parents consider that punishment is a very effective way in the 
treatment of bedwetting. A mother told me that she used to light a matchstick, blow it out 
and touch her daughter’s thigh with it as a punishment / treatment for bedwetting! Most 
parents believe that bedwetting is not a physical condition and are uncomfortable initiating 
a dialogue with physicians (Dunlop et al, 2005). 
On the other hand, a survey reported that 68% of parents said that their child’s paediatrician 
or primary care provider had never addressed bedwetting during a routine visit regardless of 
the child’s age (Dunlop et al, 2005). 
Acquisition of urinary bladder control is a significant developmental milestone for the child 
and family. This is complex, and has not been completely understood. Urinary bladder 
control is a complex learning process that consists of different stages of child development. 
Children’s development is related to their health and well-being, where growth represents 
the quantitative changes which are measurable and easily observed and studied, and 
development represents the qualitative changes that can be achieved by acquiring skills, and 
is more complex and less easily measured and studied (Erikson, 1982). 
According to Erikson (Erikson, 1982), there are eight stages of the psychosocial 
development during the human lifespan. The first three stages of Erikson’s theory of 
psychosocial development take place during the period (0 to 5 years) of age, and are 
connected to the development of urinary bladder function. In the first stage (0-1.5 year) the 
infant’s development is entirely dependent on the quality of the care provided by the parent 
or care giver. In this stage the child learn to develop basic trust. In the second and third stages 
(1-5 years) children of this category learn to take control over their body functions and feel 
independent; Erikson believed that toilet training is very important in this stage of 
development, when the child accomplishes these stages successfully confidence grows. 
Consequences for health and well-being of not controlling the urinary bladder function may 
constitute an emotional and behavior challenge for the child. These include shame, guilt and 
other problems with peers. In addition it may become a problem between the child and the 
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parent with a negative impact on the relationship between them with consequences like poor 
self-esteem and parent frustration (Dixon, Stein, 2000)  
It is obvious how important the parents are in Erikson’s theory and that they must support 
the child during the process of achieving urinary bladder control. It is also important for 
health professionals to support parents or care givers in their efforts to help their children 
become dry so they can overcome their frustration. Treatment failure or inadequacy of 
Nocturnal Enuresis (NE), can lead to psychological disturbances such as impaired personal, 
social and emotional behavior (Fergusson et al., 1986; Butler et al., 2002; Van Tijen et al., 
1998). 
1.2 Literature Review   
PubMed was searched according to PICO strategy table (1.1). 
In the first stage of the search I’ve found 439 articles, and then I started to exclude articles 
according to their title’s relevance to the research, after this stage, 145 articles remains.  All 
included articles’ references were searched to find and include other important and relevant 
articles to my research. All relevant articles were read and many of them were cited in the 
study. 
Unfortunately articles related to the purpose of the research were rare, only one article was 
found, a semi qualitative study, and highlighted six main categories of barriers that prevent 
parents to seek help. 
Table 1.1: PICO strategy 
Population Intervention Outcome 
Children Nocturnal Enuresis Management 
Young people Bedwetting Treatment 
School age Services Intervention 
 Enuresis guidelines 
1.3 What is already known about the topic? 
Enuresis is a common childhood problem which represents a very serious and distressful 
problem. Due to its high prevalence during infancy, bed wetting is considered as a 
dysfunction only after the age of 5 years (DSM IV). 
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At school age it represents one of the most frequent problems that can have a deep impact 
upon the child’s behaviour, emotional health and social life. Primary nocturnal enuresis is a 
worldwide problem. It has been described as both the most prevalent and chronic of all 
childhood problems (Collins, 1980).  
1.3.1 Definition 
Enuresis is an involuntary or unintentional bedwetting or wetting of one's pants (Comer, 
1992). Enuresis could be defined as the inability to develop urinary continence or bladder 
control after an age at which such control is normally attained by a majority of children in 
the general population (Schwartz & Johnson, 1981).  
Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM IV) defined 
enuresis as the repeated voiding of urine into the bed or clothes at least twice per week for 
at least three consecutive months in a child who is at least 5 years of age, with the absence 
of any congenital, acquired defects of the CNS or urinary tract. 
G. Smith describes enuresis as a normal voiding that takes place at an inappropriate or 
socially unacceptable time or place; importantly, the function of the bladder and urethra is 
normal. Incontinence is the involuntary loss of urine, which is demonstrable objectively and 
is a social or hygienic problem; this is associated with dysfunction of the lower urinary tract 
(G. Smith, 2007). 
Nocturnal enuresis (NE) refers to voiding during sleep, diurnal enuresis defines wetting 
while awake. All infants are enuretic, and acquisition of daytime and then night-time control 
is part of normal development (G. Smith, 2007). 
Enuresis has a clear genetic component: 44% and 77% of children were enuretic when one 
or both parents, respectively, were themselves enuretic (G. Smith, 2007). 
1.3.2 Classification 
The word enuresis is derived from a Greek word (enourein) that means “to void urine.” It 
can occur either during the day or at night. The terms of bedwetting and nocturnal enuresis 
indicate involuntary urine voiding occurring during the night while the child is sleeping. 
Diurnal enuresis means that involuntary urine voiding occurs during the day while the child 
awake (Lane & Robson, 2014).  
Nocturnal Enuresis can be classified, according to the absence or presence of symptoms, into 
monosymptomatic or non-monosymptomatic. Monosymptomatic enuresis occurs in the 
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absence of any daytime voiding symptoms, such as frequency, urgency, or daytime 
incontinence. Nonmonosymptomatic enuresis is more common; when a detailed history is 
obtained, the majority of children have at least subtle daytime symptoms. This subgrouping 
is essential because, children with Lower Urinary Tract (LUT) symptoms, such as 
increased/decreased voiding frequency, daytime incontinence, urgency, hesitancy, straining, 
a weak stream, intermittency, holding manoeuvers, a feeling of incomplete emptying, post-
micturition dribble and genital or LUT pain, differ clinically and therapeutically  from 
children without these symptoms (ICCS, 2006). 
Enuresis can also be categorized into primary and secondary forms. Secondary enuresis is 
defined as wetting that develops after a minimum of 6 consecutive months of dryness. The 
clinical presentations of children with primary and secondary enuresis are otherwise similar, 
which suggests a common pathogenesis (Lane, & Robson, 2009). 
1.3.3 Prevalence  
Nocturnal enuresis is a very common occurrence in younger children. In the literature the 
prevalence is quoted as 15-20% in five years aged children (ERIC, 1995).  
Many epidemiological surveys in western countries suggest that the prevalence for boys is 
around: 13-19% at5 years, 15-22% at 7 years, 9-13% at 9 years and 1-2% at 16 years, while 
the prevalence rates for girls are reported to be: 9-16% at 5 years, 7-15% at 7 years, 5-10% 
at 9 years and 1-2% in the late teenage years (Devlin, 1991). 
Enuresis is more common in males. The reported prevalence of enuresis at the ages of 7 and 
10 years are 9% and 7%, respectively, in boys and 6% and 3%, respectively, in girls. No 
racial predisposition has been documented (Lane, & Robson, 2014).  
According to Wm Lane and M Robson the prevalence of enuresis gradually declines during 
childhood. Of children aged 5 years, 23% have enuresis, in elementary school age children 
10% of 7 years old children and 4% of 10 years old children still have enuresis (Lane, & 
Robson, 2014). In adults the reported prevalence is 0.5-2% 49 (Schwartz & Johnson 1981).   
This gradual reduction in prevalence with age has previously led to the conclusion that 
children will ‘grow out of it’ and the condition has been often minimized. In fact many 
researches showed that this distressing condition can have a deep impact on emotional 
wellbeing and social development. Children and young people with this condition often miss 
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on opportunities to participate in school activities such as sleep over in school trips and they 
will start to feel “different” (ERIC, 1995). 
There is evidence that bedwetting and combined wetting are associated with parent-reported 
psychological problems and children behaviour problems (Joinson, Heron, Emond, Butler, 
2007) and stress within families can be considerable with an increased risk of child 
punishment including child abuse (Melina, Juliana, Fernando, Ronaldo, Eloísio, 2009). 
Epidemiological surveys to determine the prevalence of (NE  ( in Arab countries are 
infrequent. A cross-sectional survey conducted on the public primary school in Aden, 
Yemen32showed that the prevalence of (NE) was 17.2%, which is similar to that reported in 
a study done in Ankara, Turkey (17.2%) and the UK (18.9%), but lower than that reported 
in Al Mukala primary school, Hadramout, Yemen (28.6%) Zaria, Nigeria (22.2%), and 
Amman, Jordan (23.8%), but higher than the prevalence reported in Mumbai, India (7.61%), 
Malaysia and United Arab Emirates (each 8%), and Tafila, Jordan (8.8%) (Yousef, 
Basaleem, Yahiya, 2011).  
In another cross-sectional study conducted in Amman, Jordan showed that bedwetting was 
commoner in boys than girls. The prevalence rates among boys and girls were 33.7%, and 
15.7% respectively. The overall prevalence rate of primary nocturnal enuresis (PNE) 
declined with age from 48.9% at 6 years to 21.1% at 7 years and 8.4% at 8 years. Family 
history of enuresis was present in 50.5% of the cases, while low socioeconomic class was 
found in 67.3%. Fifty percent of the parents sought medical help and 75% of the children 
received drug therapy. At least 14% of parents reacted with anger and punished their children 
at some time. The overall prevalence of PNE in Jordanian children was 23.8%, this is higher 
than the 8-15% reported by others (Hazza, & Tarawneh, 2002). 
Nocturnal enuresis (NE) is defined as the involuntary urine voiding during the night by a 
child who is old enough to be expected to have bladder control. When bladder control has 
never been attained his condition is named primary nocturnal enuresis (PNE). 
1.3.4 Assessment  
Four important goals should be achieved when assessing children or young people with NE, 
to establish the diagnosis, to find out what the parent/child wants, to rule out or identify 
underlying causes and to identify the factors that will influence choice of management 
strategy” (NICE Clinical Guidelines, No. 111, 2010). When daytime urinary symptoms are 
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present a detailed history of these symptoms (Table 1.2) should be carried out to determine 
whether the condition is monosymptomatic or non-monosymptomatic 34a very important and 
crucial moment because the management differs. In this research, monosymptomatic 
enuresis constitutes the subject. Treatment and care delivered to the patients should be 
culturally appropriate and accessible to patients with special needs such as learning and 
physical disabilities (NICE Clinical Guidelines, No. 111, 2010).  
In decision making process concerning treatment and care, parents should be involved. This 
should be with the child’s agreement for older children (NICE Clinical Guidelines, No. 111, 
2010).  
It is important that parents understand that their children are not wetting the bed deliberately 
and that enuresis is not voluntary. So, punitive measures should not be used in the 
management of enuresis (Goel, & Gupta, 2012).  
Table 1.2 Daytime urinary and bowel symptoms  
Symptoms                             Monosymptomatic 
Nonmonosymptomatic 
without diurnal enuresis 
Nonmonosymptomatic                                                                     
          with diurnal enuresis 
Urge incontinence - + +++ 
Dribbling - + ++ 
Weak stream - + ++ 
Holding maneuvers - + ++ 
Feeling of incomplete emptying - + + 
Constipation + _ NA 
Wetting during nap + + +++ 
Encopresis + + +++ 
Intermittency _ _ + 
Decrease voiding frequency _ _ ++ 
Encopresis and Constipation _ _ + 
(Naseri, & Hiradfar, 2012). 
Many health organizations, institutions and researchers have been elaborated guidelines, 
pathways and approaches to assess, diagnose and treat children with nocturnal enuresis. 
It is important to understand that the diagnosis Primary Monosymptomatic Nocturnal 
Enuresis (PMNE), is made by exclusion, so, in order to exclude other types of nocturnal 
enuresis we should take a thorough history of the condition.  
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A rapid screening series of questions can help in categorizing children with NE, such 
questions are listed in (Table 1.3). 
Table 1.3 “Rapid screen to determine type of enuresis”  
Question If response is positive, then consider 
Previously dry in the last 6 months                                                         NMNE or SNE 
Associated with daytime urine control issues NMNE 
Constipation or fecal soiling                                                                          NMNE
Severe recent stress                                                                                          SNE
If responses to all above questions are negative, then 
consider             
MNE 
MNE=monosymptomatic nocturnal enuresis NMNE=nonmonosymptomatic nocturnal enuresis SNE=secondary nocturnal enuresis.  
(Bayne, & Skoog, 2014). 
This rapid screening is the first step in order to categorize the condition then, a thorough 
history should be carried out where all symptoms listed in (Table 1.2) must be fully explored 
in order to be excluded or not, depending on the case. 
After history taking and physical examination performed, physicians should ask about the 
child’s motivation for treatment and, how much this problem is bothering him. Behavior 
modification can succeed, only if the child is interested in participation (Bayne, & Skoog, 
2014). 
A very interesting and important “Key priorities for implementation” elaborated by NICE 
clinical guideline 111 pp 7-8 (NICE Clinical Guidelines, No. 111, 2010). In these priorities 
we can notice the translation of the “patient-centered care” concept into the clinical practice, 
this involvement in all stages of treatment will increase the adherence to the process and 
contributing to the success of the treatment. 
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Chapter II 
Primary Monosymptomatic Nocturnal Enuresis (PMNE)  
2.1 Definition:  
Monosymptomatic enuresis is defined as the involuntary urine voiding during the night in 
the absence of any daytime voiding symptoms, such as frequency, urgency, or daytime 
incontinence. 
2.2 Etiology 
Many etiological theories have been proposed with the cause of nocturnal enuresis now 
considered as heterogeneous. A new model has been elaborated in order to facilitate the 
clinical understanding. Based on the empirical findings this new model termed “three -
systems model” considers that bedwetting results from excessive nocturnal urine production 
(Inadequate nocturnal vasopressin production) and/or nocturnal bladder over activity (BOA) 
coupled with an inability to arouse to bladder sensations (Butler, 2004)   
2.2.1 Inadequate nocturnal vasopressin production 
The hypothalamic/pituitary axis, normally, increases the release of vasopressin overnight 
causing a decrease in urine production; many children with NE lack this nocturnal rise of 
vasopressin release and, resulting in increased nocturnal urine production and disparity 
between nocturnal urine production and urinary bladder capacity (Rittig, & Knudsen, & 
Norgaard, & Pedersen, & Djurhuus, 1989). 
Another aspect of urine production, which is not related to vasopressin release, is seen in 
children with nocturnal polyuria (NP), this condition is defined “as urine production greater 
than 130% of the child’s expected bladder capacity” (Bayne, & Skoog, 2014).  
“It is important to evaluate children with NP for conditions that raise the likelihood 
of nocturnal diuresis, such as sleep disordered breathing, heart abnormalities, 
metabolic conditions, and/or excess nocturnal fluid and solute intake. Sleep 
disordered breathing in particular has been the subject of many studies and is well 
known to cause or be associated with PMNE” (Bayne, & Skoog, 2014). 
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2.2.2 Bladder over activity 
30-32% of children with (NE) have uninhibited bladder contractions (Watanabe, Imada,   
Kawauchi, Koyama, Shirakawa, 1996).This is associated with a smaller functional bladder 
capacity FBC (Watanabe, & Kawauchi, 1995). Children with overactive bladder usually 
failed to respond to desmopressin or an alarm system (Yeung, & Chiu, & Sit, 1999). 
Frequent daytime voiding (more than seven per day), urgency, low or variable FBC, small 
voided volumes, variability in the size of wet patch in the bed and waking during or 
immediately after wetting are clinical identifiers of overactive bladder. 
2.2.3 Inability to arouse 
Most of the parents describe their enuretic children as difficult to arouse or heavy sleepers. 
Normally, children can wake spontaneously to void, enuretic children are unable to wake 
spontaneously to void (Bower, Moore, Shepherd, et al.1996). 
Failure to arouse from sleep when the bladder reaches its maximum capacity seems to be the 
problem, and this has been confirmed through EEG studies (Watanabe, Imada, Kawauchi, 
Koyama, Shirakawa, 1996). So it is crucial to understand that difficulty with sleep arousal 
is central to all children with all types of (NE) (Bayne, & Skoog, 2014). This sleep disorder 
is characteristic in children with monosymptomatic nocturnal enuresis and, differentiates 
them from children who have nocturia where the child is able to awaken and void (Bayne, 
& Skoog, 2014). Also it is important to assess the child’s wake ability before initiating 
treatment, as the success of an intervention such as the enuresis alarm is dependent on the 
child’s responsiveness to the alarm triggering (Gontrad, Schaumgurg, Hollman, Eiberg, 
Rittig, 2001).  
2.2.4 Genetic factors 
Genetic predisposition has strong evidence, but the exact mechanism of inheritance of 
nocturnal enuresis is unknown. A comprehensive review of the published data on the genetic 
basis of enuresis performed by Alexander von Gontard et al. concluded that genetic factors 
are the most important in the aetiology of nocturnal enuresis but somatic and psychosocial 
environmental factors have a major modulatory effect (Gontrad, Schaumgurg, Hollman, 
Eiberg, Rittig, 2001).  
2.2.5 Maturational delay 
One of the most common accepted cause of nocturnal enuresis, but also the most difficult to 
prove, is delayed functional maturation of the central nervous system, which reduces the 
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child's ability to inhibit bladder emptying at night. The child's bladder will fill, but the 
sensory output resulting from the stretching of the bladder is not perceived or is not sent to 
the brain and, thus, central cortical control over the urinary sphincter contraction does not 
occur. Failure of the arousal mechanism may also contribute to the inability to inhibit 
micturition (Cendron, 1999). 
2.2.6 Psychological factors 
Psychological stressors have long been thought to play a role in enuresis. In the great 
majority of cases, nocturnal enuresis is not caused by psychological factors; instead the 
enuresis creates secondary psychological problems for the child, especially affecting self-
esteem (Tietjen, & Husmann, 1996; Cendron, 1999).  
2.3 Treatment of PMNE 
All enuretic children need a comprehensive history taking and an evaluation of daytime 
voiding symptoms or comorbidities to differentiate subgroups of nocturnal enuresis, once 
the diagnosis is accurately established professionals can proceed to treat the condition. The 
majority of children with monosymptomatic nocturnal enuresis can be treated efficaciously 
(Walle, & Rittig, & Bauer, & Eggert, & Marschall-Kehrel, & Tekgul, 2012). 
A thorough explanation of the condition, its implication and impact on the child and his 
family and an assessment of the motivation degree of the child are very helpful.  
Myths and other beliefs should be discussed with the parents, just like “the child is 
misbehaving and should be punished for wetting his bed”, parents can encourage him/her to 
clean his/her bed but physical punishment should not be part of any treatment (Nield, & 
Kamat, 2004). 
Children with PMNE can be treated in primary health care settings by physicians or 
adequately educated nurses (Neveus, Eggert, Evans, et al., 2010; O'Flynn, 2011). 
A significant decrease in wet nights, higher cure rates and lower relapse rates were results 
of a systematic review of simple behavior interventions compared with controls. Such 
interventions are reward systems, star chart for dry nights, lifting or waking the children at 
night to urinate, there wasn’t enough evidence to evaluate retention control training 
(stretching the bladder) and fluid restriction (Glazener, Evans, 2002; Glazener, Evans, 2004; 
Caldwell, Nankivell, Sureshkumar, 2013). 
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As general measures all children should restrict fluid consumption during the evening hours 
only. In order to prevent an excessive thirst or dehydration at the end of the day which makes 
the child to drink more fluids, an adequate hydration during the day and at school should be 
provided. 
Many difficulties with fluids intake can occur, some of the enuretic children deliberately 
limit their fluid intake during the day and at school, this may be due to bladder dysfunction 
or toilet related anxieties, which result in more fluid consumption before bedtime. A 
schedule of fluids consumption can help to overcome this problem, children can drink two-
thirds of their fluids before the end of the school day then one- third of the fluids in the 
evening, no fluids intake is permitted in the last hour before bed. Children who have 
activities, sport or other physical activities should be hydrated adequately. Fluids intake 
control should not affect adequate hydration of the child.  
Arousals difficulties, which constitute one of the mechanisms implicated in NE’s aetiology, 
can be overcome by establishing a stable and reliable bedtime routine, to eliminate excessive 
fatigue. Restless enuretic children are difficult to respond bladder stimulation or alarm 
systems (Bayne, & Skoog, 2014). 
Bladder advice, bed alarm and desmopressin are first line therapy. Resistant cases should be 
referred to a specialist doctor. Anticholinergics and imipramine were selected as second line 
treatments (Neveus, & Eggert, & Evans, et al., 2010). 
Bedwetting alarm and desmopressin were recommended by the International Children 
Continence Society (ICCS) as first line interventions for children with primary 
monosymptomatic nocturnal enuresis (PMNE). 
2.3.1 First – line treatment 
Enuretic children between five and seven years of age have not been offered treatment. NICE 
has published a guideline on the assessment and treatment of enuretic children with 
recommendation for children less than seven years. 
2.3.1.1 Enuresis alarm 
This is one of the most effective and has the best long term cure rate and has a level 1, grade 
A ICI (International Consultation on Incontinence) recommendation. It involves the whole 
family and, parents should understand that, because of its disruptive nature, it requires a 
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significant commitment in time and effort; therefore, only motivated children and families are 
advised to participate. Also, parents are advised to wake their children when the alarm starts, 
otherwise children tend to turn it off and go back to sleep (Bayne, & Skoog, 2014; Walle, & 
Rittig, et al., 2012). 
The response to an alarm is not immediate and it should be continued for 2-3 months or until 
the child achieve 14 consecutive dry nights (whichever comes first).Children from families 
who are committed to the treatment for a significant period can achieve a high rate response 
with low rate relapse. Despite this findings cure rates are still less than 50% (Glazener, Evans, 
Peto, 2005). Child behaviour problems and parent intolerance may lead to the early 
termination of the treatment (Wagner, Johnson, 1988). Therefore, alarm treatment may not be 
suitable for some families, in these cases desmopressin may be an alternative.  
Children who achieved 14 consecutive dry nights should be advised to contact the clinic if 
relapse occur and a second trial should be considered (Walle, & Rittig, & Bauer, & Eggert, & 
Marschall-Kehrel, & Tekgul, 2012). 
2.3.1.2 Desmopressin 
This is a vasopressin analogue that reduces the amount of urine production overnight, it has a 
level1, grade A ICI recommendation in 2009.Two different formulations of desmopressin are 
available, oral tablet and orally disintegrating lyophilisate tablet (melt).At doses of 200/400 
μg for the tablet and 120/240 μg for the melt, these two formulations have been shown to be 
clinically bioequivalent. Due to low food interaction the melt formulation is more suitable for 
the younger age group with a limited interval between meal and drug administration (Juul, 
2013; De Guchtenaere, Van Herzeele, Raes, et al., 2011). 
A randomized double-blind placebo-controlled study (Vande Walle, Bogaert, et. Al., 2006), 
concluded that: 
“Oral lyophilisate causes a marked decrease in urinary output in hydrated children 
with PNE. A small dose range (120-240 microg) is likely to control diuresis for a 
period corresponding to a night's sleep (7-11 h) in most children with PNE. However, 
some patients might require a higher dose to obtain antidiuresis for the complete 
night”. 
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Many guidelines recommend giving desmopressin 1 hour before the last voiding before 
bedtime and to reduce fluid intake, 1 hour before desmopressin is given, until the child wakes 
next morning.  
According to NICE clinical guideline, when desmopressin is considered for treatment the 
child and his/her parents should be informed that a reduction in wetness is expected 
immediately but relapse can occur when treatment is withdrawn, fluid should be restricted1 
hour before desmopressin is given, until the child wakes next morning, desmopressin should 
be taken at bed time, treatment should be continued for 3 months; and repeated courses can 
be used after a break period (O'Flynn, 2011). 
Parents should be counselled about the risk of hyponatremia associated with desmopressin 
administration. The risk of this complication is higher when nasal spray is used (Bayne, & 
Skoog, 2014). Because of this nasal spray is not recommended. 
Structured desmopressin withdrawal program improves response to treatment and it is 
superior to regular treatment with abrupt termination (Marschall-Kehrel, & Harms, 2009). 
In a randomized trial study (Evans, & Malmsten, & Maddocks, & Popli, & Lottmann, 2011) 
to compare the efficacy of long-term primary nocturnal enuresis treatment using 
desmopressin versus enuresis alarm, a similar proportion of patients across groups showed 
a ≥ 50% reduction in wet nights/week (desmopressin: 37.5%, alarm: 32.2%) and achieved 
dryness (desmopressin: 32%, alarm: 37%). Desmopressin shows a higher compliance 95-
98% of patients took >75% of tablets, 50-78% used alarm >75% of nights. Approximately 
32% of patients withdraw early from the alarm group, this high withdrawal percentage 
indicate the importance of considering family motivation before selecting treatment. If 
children show no improvement with one first-line treatment, despite adherence, an 
alternative therapy should be tried. 
2.3.2 Second line treatment  
2.3.2.1 Combined therapy, Enuresis alarm and desmopressin 
Cases with refractory primary nocturnal enuresis may benefit from combined drug therapy 
when neither the alarm nor pharmacologic therapy has been effective. 
A retrospective analysis study to evaluate the combination of the enuresis alarm and 
desmopressin concluded that “children who need the addition of desmopressin have a higher 
  
14 
 
nocturnal urine production in wet nights but do not seem to differ in terms of bladder 
reservoir function characteristics” (Van Tijen et al.1998) . 
Another randomized control trial (Ahmed, & Amin, & Ali, & Shalaby, 2013) randomly 
assigned Saudi children, in three groups, to receive an Enuresis Alarm alone (EA group), 
Desmopressin alone (D group) or a combination of both (EA/D group).Patients were 
followed weekly during treatment and for 12 weeks after treatment withdrawal. Results 
showed a significant difference, only between the EA and EA/D groups (p=0.025). 
Relapse rates were higher in the D group (66.6%) than in the EA (16.6%) and EA/D (33.3%) 
groups. A significant difference was observed between the D and EA groups only (p=0.019). 
Effectiveness was seen in all groups, desmopressin produce an immediate response but 
relapses were common, enuresis alarm produce a gradual response that persists after the 
treatment.  
The combined therapy was superior to the alarm in achieving an immediate response; 
however, its effect was not better than that of the alarm long term. 
This combined therapy should be reserved to resistant cases where parental intolerance is 
eminent.  
2.3.2.2 Anticholinergics 
These drugs act on smooth muscle by inhibiting acetylcholine, they are also called 
parasympatholitics. They are used to treat spasms or conditions with disturbances in the 
bladder or gastrointestinal motility. 
Anticholinergics are used in children with small or overactive bladders with frequent 
voiding, they have the effect of decreasing the urge to pass and allow the bladder to hold 
more urine (NICE Clinical Guidelines, No. 111, 2010). 
The recommended dose is 5 mg of Oxybutynin; this may be increased to 10 mg in older 
children or 2 mg of Tolterodine at bedtime. Constipation is the common side effect of 
anticholinergics, children who receive these drugs should be monitored for constipation 
since it can impact negatively the results (Bayne, & Skoog, 2014).  
They are used in certain specific situations when their use is justified and recommended. The 
International Children Continence Society (ICCS) recommends its use only after 
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desmopressin or the alarm therapy has failed. In monotherapy they are not effective in the 
treatment of PMNE they may be used in combination with desmopressin to increase bladder 
capacity over the night in children who has NE with daytime incontinence (Naiwen, & 
Baskin, 2014). 
2.3.2.3 Tricyclic antidepressants 
Tricyclic antidepressants (imipramine, amitriptyline, and desipramine) are a third-line 
treatment for monosymptomatic enuresis. Due to their potential side effect (cardiac 
arrhythmias, hypotension, hepatotoxicity, central nervous system depression, interaction 
with other drugs, and the danger of intoxication by accidental overdose), tricyclics are 
reserved for treating resistant cases only. Imipramine in combination with Oxybutynin may 
be superior to monotherapy (Glazener, & Evans, & Peto, 2003). 
Before starting treatment with these drugs, parents and children should know that: 
 Not all patients will achieve a reduction in the number of wet nights. 
 The drug should be taken at bedtime. 
 The dose should be increased gradually. 
 Most of the children relapse after stopping treatment. 
 Serious adverse effect of drug overdose.  
 The initial treatment course is for 3 months, further courses may be considered. 
 
The dose of imipramine is 25 to 50 mg at bedtime. Imipramine should be withdrawn 
gradually when stopping treatment for bedwetting in children and young people (NICE 
Clinical Guidelines, No. 111, 2010).  
Despite their effectiveness in reducing the number of wet nights, tricyclics and 
desmopressin, in comparison with alarm treatment, have higher rates of relapse after 
stopping the treatment. Only half the children will relapse after alarm treatment (Glazener, 
& Evans, Peto, 2003).  
Current guidelines suggest that use of imipramine should be limited to specialty centers with 
extensive experience treating PMNE. Imipramine has been found to have a risk of QT 
prolongation in children, and a careful cardiac history for the child and the family should be 
obtained before starting use of the medication (Bayne, & Skoog, 2014). 
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2.3.2.4 Other Treatments 
Two recent systemic reviews where 31 Randomized Control Trials involving 2490 patients 
concluded that: 
1. Hypnosis, psychotherapy, acupuncture and chiropractic had a weak evidence to 
support their use. The evidence was provided in each case by single small trials, some 
of them of poor quality, these interventions have a promising potential but need more 
data from quality randomized trials to be recommended (Glazener, & Evans, & 
Cheuk, 2005). 
2. Dry Bed Training (DBT) and Full Spectrum Home Training (FSHT) were efficient 
when used with an alarm but, there was insufficient evidence to support their use 
without alarm. There was some evidence that shows an augmentation of alarm use 
when combined with DBT (Glazener, & Evans, & Peto, 2004). 
Resistant cases of PMNE 
When the improvements in symptoms are less than 50% despite treatments and active 
intervention the condition is labeled as nonresponsive or refractory nocturnal enuresis. In 
this situation, possible causes of treatment failure should be carefully investigated, (Table 
2.1) (Bayne, & Skoog, 2014) include some of these possible causes with suggestion for the 
next step. Possible treatment protocols for MNE are given in Table (2.2) (Bayne, & Skoog, 
2014). 
Table 2.1: Possible Reasons for Treatment Failure of Enuresis  
CAUSE                                                                 NEXT STEP 
Constipation or retained fecal 
burden 
Bowel regimen 
Occult voiding dysfunction Behavioral therapy, post void residual volume, 
uroflowmetry 
Treatment compliance failure Family goal discussion and assessment of child’s 
interest in participation 
Neurologic condition Detailed neurologic examination and consider 
lumbar magnetic resonance imaging 
Psychological stressors Psychological evaluation and counseling as 
needed 
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Metabolic concerns Laboratory evaluation and consider endocrine 
referral 
Sleep disorders Sleep laboratory referral with polysomnography 
Sleep disordered breathing Sleep specialist referral or otolaryngologist 
referral 
                                                                                                         (Bayne, & Skoog, 2014). 
Table 2.2: Possible Treatment Protocols in MNE  
TYPE OF MNE TREATMENT 
All cases Limit fluids before bed (£200 mL) 
 Void before bed 
 Regular sleep and wake schedule 
Classic PMNE                                                                             Alarm (first)
 Desmopressin (second) 
Nocturnal polyuria                       Desmopressin 
Sleep disordered breathing                                                                                                      Sleep study or referral to an otorhinolaryngologist
Small bladder capacity Alarm 
Overactive bladder (suspected) Desmopressin and oxybutynin 
 Alarm and oxybutynin 
Small bladder and nocturnal 
polyuria                       
Desmopressin and alarm (consider oxybutynin as 
well) 
MNE = monosymptomatic nocturnal enuresis PMNE = primary monosymptomatic nocturnal enuresis. 
                                                                                                        (Bayne, & Skoog, 2014). 
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Chapter III 
Data collection and data analysis 
3.1 Materials & Methodology 
This study was designed as a qualitative descriptive cross – sectional study.  There were two 
parts to the questionnaire, section I and section II. Section I, directed to the parents, was a 
structured questionnaire aiming to collect demographic data. Section II; open-ended 
questions were used to determine if there were barriers that parents and their children faced. 
Interviews with social workers from the eight medical centers that were involved in the study 
were performed. In addition, two elementary schools, boys and girls from Qalqilia belonging 
to UNRWA, were visited and, separated interviews with every social worker were 
performed. Interviews with Medical Officers working within UNRWA medical centers were 
performed also, to explore if they are adopting and using any local technical instruction or 
other national or international guidelines. 
Initially, the questionnaire was comprehensive containing general demographic questions, 
(section I), for demographic data acquisition and a special part, (section II), with direct and 
narrative questions to find out barriers. Considering the fact that the purpose of this study is 
not to collect demographic data, it was decided to use only section II. Pilot testing both 
sections, showed lack of answers to the questions included in section II. I attributed this 
result to the fact that questioned families already attend our medical centers for assessing 
and treating their enuretic children. Therefor I decided to use the questionnaire in its two 
parts, (section I and section II), in this way, the study will be enriched and demographic data 
acquisition and analysis may be helpful to get an overview of the problem and to open new 
horizons for future researches. 
Forty questionnaires were distributed in the eight northern medical centers from West Bank, 
5 questionnaires for every center. 37 were returned; of these 20 were male children and 17 
female children. The first five families who attend the clinic because of nocturnal enuresis 
were given the questionnaire. 
3.2 Data analysis & Results  
The total number of children with PMNE included in the study was 37 aged between 7- 12 
years old; the modal age was 7-8 years old (Figure 3.1).  Of the total number of studied 
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children 20 (54.1%) were males while 17 (45.9%) were females. The ratio male to female is 
1.2: 1.  
The majority (64.9%) were from refugee camps and 29.7% from cities. This is a normal 
finding due to the fact that seven of the eight health centers studied, are situated inside the 
camps. 
Fig. (3.1)  Age frequency (year) 
 
The number of families’ members varies 83.8% 4-8 members. For the educational level of 
the parents, 20.3% have university degree, 37.8% finished high school and 41.9% didn’t 
finish high school. Approximately 29.7% described their socio-economic status as good, 
43.2% as middle and 27% as poor. 
None of the studied children had only diurnal enuresis, 78.6% had nocturnal enuresis while 
21.4% had both nocturnal and diurnal. 
91.9% of the children had been toilet trained, of them 44.1% at the age of 2 years, 26.5% at 
1.5 years and 14.7% at 6 years of age.  
  
20 
 
The relationship between the child and his family was found; positive in 64.9% tense; 18.9% 
weak; 16.2%. Physical punishment was used in 21.6% of the children.  
Positive family history of nocturnal enuresis was common, the percentage was 
83.8%.Children’s attitude was 24.3% careless, 67.6% shy or sad and 8.1% angry, 40.5% 
humiliated, insulted or bullied. 
Children’s reasons to overcome bedwetting;  32.4% to avoid humiliation, 24.3% to be equal 
with his peers, 16.2% to build self-confidence, 10.8% to participate in school activities and, 
16.2% had more than one reason (Figure 3.2). 
When caregivers were asked if they attend UNRWA health centers to seek help in resolving 
their enuretic children problem, 18.9% declare no, reasons for not attending our health 
centers, lack of awareness, time and family problems were evoked. 
Fig. (3.2) Children’s reasons to overcome bedwetting 
 
Treatment satisfaction was found in 76.7% while 10% were not satisfied and 13.3% could 
not tell. Reasons for dissatisfaction were; lack of improvement, absence of drug treatment 
and doctors’ opinion that the child will “outgrow of the condition”.  For different reasons, 
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35.1% stopped to attend the clinics. A list of these reasons is shown in (Table 3.1) Some of 
the caregivers 32.4% sought treatment in another health provider centers. 
Table 3.1 List of reasons for not attending the clinics 
Reasons                                                                                Percentage 
Father refusal to continue treatment                                                                15.4% 
Treatment failure 30.8% 
Family problems                                                                          23.0% 
Lack of time                                                                  30.8% 
 
3.2.1 Interviews 
A. Two interviews with schools social workers were held.  
The first interview was with boys’ elementary school social worker, the total number of pupil 
who attends the school was 467pupils. Of them, only 15 cases 3.2% have been taken in the 
social worker’s evidence, for follow up, as enuretic children. None of them was referred to 
physicians. The main reasons suggested were:- 
1. Social stigma 
2. Family denial  
3. Lack of communication between children and their families are the barriers of not 
accepting medical referrals or follow up sessions, even not declaring the condition, he 
said.     
The second interview was with the girls’ elementary school social worker, the total number 
of pupil was 750 pupils. Of them only 4 cases 0.5% was registered as enuretic. In addition 
to the barriers mentioned by boys’ school social worker, 
1. Parental lack of awareness and of understanding the condition was another barrier 
according to girls’ school social worker. 
 
B. Interviews with social workers from UNRWA health centers in northern West 
Bank. 
These interviews were conducted with every social worker from the eight northern health 
centers. Many reasons were mentioned as barriers. 
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1. Parental lack of information about the condition, some of the mothers believed that the 
condition is normal, because of its personal experience as an enuretic child.  
2. The only therapeutically interventions were psychological and behavioral conducted by 
the social workers, while the involvement of physicians, was not enough which led to 
parental dissatisfaction.  
3. The relationship with the medical officers is insufficient, the feedback system doesn’t 
work. 
4. Absence of technical instructions constitutes another barrier to approach the problem 
systematically.  
C. Interviews with medical officers from UNRWA health centers in northern West 
Bank.  
Reasons identified as barriers to effective treatment were: 
1. The absence of precise technical instruction, guidelines and pathways to assess and treat 
the condition.  
2. Medical officers are working according to their personal understanding and knowledge 
of the problem.  
3. The majority of the medical officers proceed to refer the enuretic children to the social 
worker after a clean urinalysis result.  
4. In this mode, the psychological aspect of the problem was considered, but other aspects 
weren’t.  
As an UNRWA medical officer employee I, myself, used to proceed in this manner until I 
was involved seriously in this medical condition.  
Barriers that prevent parents to seek help. 
No articles were found in the literature that proposed to survey communities in order to find 
out any barriers or obstacles that prevent parents or their children to seek medical help to 
overcome their condition. 
One article, a semi qualitative study (Henry, 2009), highlighted six main categories of 
barriers that prevent parents to seek help. 
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These six main categories are:- 
1. Language/understanding:  
Parents had a low awareness of causes and effects of continence problems; inability to 
understand the psychology of continence problems and discuss things with their child; 
and possible language difficulties. 
2. Motivation:  
Stigma; difficulty in talking about problems; a general belief that after years of dealing 
with the problems ‘nothing will help’; and had been told their child would grow out of it 
naturally. 
3. Knowledge:  
Parents do not know how to access help; there is insufficient accessible information; 
healthcare professionals may not be proactive in offering what is available; and there is 
insufficient outreach by healthcare professionals to those who most need help. 
4. Cost: 
 Parents are afraid that help will cost them more money; they do not know what is free; 
and they may not claim benefits to which they are entitled because they do not know they 
are available. 
5. Time:  
Accessing help takes time and energy. Many of the parents have more than one child and 
often more than one child with continence problems. Inappropriate referrals and long 
delays meant that some parents waited two years or more before seeing the right person. 
6. Stress:  
Parents become depressed and stressed and they may ask for medical help for themselves 
rather than the child. Depression also results in demotivation and lack of action. 
3.3 Discussions  
Nocturnal enuresis is a very stressful medical condition that has its impact on the child and 
his family, parents’ and children’s lack of awareness and in information about the condition 
make them to ignore or refuse to seek medical help. In this study it is difficult to find out 
why parents with enuretic children do not attend the clinics, the sample was made from cases 
who already attend the clinics, and only a survey for local community or even to the national 
scale can accurately answer this question. Approximately 35% of cases included in the study 
stopped attending the clinics due to different causes (Table 3); lack of time, treatment failure, 
family problems and father refusal were the most evoked causes. 
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Despite that nocturnal enuresis is a common problem; it is not a priority in the training 
programs for medical professionals (Walle, & Rittig, et al., 2012). The absence of unifying 
set of recommendations for a diagnostic and management algorithm of enuresis undermine 
the success of the treatment.  
3.4 Conclusions and recommendations  
Lack of awareness, time and information, treatment failure, father refusal and family 
problems, constitute the main problems that families faced while trying to treat their enuretic 
children. In addition, the absence of technical instructions, guidelines and diagnostic and 
management algorithms make the success of the treatment limited at present. 
To overcome this and to enhance attendance to the clinics and the management a number of 
measures should be taken. I recommend:- 
 To improve people mainly parents and child’s caregiver’s knowledge and education by 
clear massages, new brochures that explain clearly the condition. 
 To involve health professionals, medical officers, more in the assessment, management 
and follow up, it is not enough to do laboratory tests and to refer children to the social 
workers. 
 To raise and improve school’s social workers knowledge and awareness on how to 
discover all possible non-medical cases of PNE among children at their schools. 
 To develop more effectively the relationship, referral and the feedback system should be 
more effective between social workers and medical officers. 
 Clear pathways, flowcharts, algorithms, (see annexes), better planning and good 
guidelines to be provided to the professionals.  
 To involve the local community in campaigns to increase awareness of this condition 
and to trigger initiatives to help these children.  
 New researches in a national scale to gather accurate information concerning all aspects 
of nocturnal enuresis.  
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Annex 1.  Flowcharts summarizing recommended evaluation of children with 
enuresis.   
 
A. Minimal Strategy  
 
 
 
 
 
 
Child ≥5 years
who wets bed
Advice
(eg causes, fluid and food intake)
CMT questioning
Physical examination and dipstick
Symptoms suggestive of bladder
dysfunction/comorbidity?
YES:
Treat these first/refer if
necessary
NO: MNE
Advice on treatment options:
shared decision based on preferences,
motivation and diary if completedh[okjh[ojik
Alarm Desmopressin
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Annex 2.  Flowcharts summarizing recommended evaluation of children with 
enuresis.   
B. Optimal Strategy  
 
 
 
CMT= Clinical Management Tool 
MNE=Monosymptomatic Nocturnal Enuresis 
MVV= Maximum Voided Volume 
NP=    Nocturnal Polyuria  
Child ≥5 years
who wets bed
Advice
(eg causes, fluid and food intake)
CMT questioning
Physical examination and dipstick
EXTENSION
Night + daytime Diary
Symptoms suggestive of bladder
dysfunction/comorbidity?
YES:
Treat these first/refer if necessary
NO: MNE
Advice on treatment options:
shared decision based on preferences,
motivation and diary if completedh[okjh[ojik
Alarm 
(reduced MVV)
Desmopressin
(NP)
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Annex 3.   Checklist clinical management tool (CMT) 
Signs and symptoms 
Presence 
Absence 
Consider 
Referral if positive (R) 
P A 
Nocturnal enuresis Yes No  
Does the child wet the bed? 
 Number of nights per week -------------------- 
Yes No  
Establishes severity, which is suggestive of prognosis    
Age ≥ 5 years Yes No  
Younger patients are likely to experience spontaneous resolution 
without intervention; treatment only considered in children 5 years 
   
Symptoms suggestive for underlying bladder dysfunction 
Leakages of urine during the day 
 Drops of urine in the underpants 
o Before voiding 
o After voiding 
 Very wet underpants 
 Frequency of leakage (N = episodes per day) 
 Intermittent or continuous leakage every day? 
 History of daytime incontinence over 3½ years of age 
Yes No R 
Suggestive of overactive bladder/NMNE    
Urinary frequency (# of voids) (≥ 8 x/day)? Yes No R 
Suggestive of dysfunctional voiding    
Sudden and urgent need to urinate? Yes No R 
Suggestive of overactive bladder    
Holding maneuvers observed (e.g. Vincent’s curtsey – pressing 
heel 
into perineum, leg crossing, standing on tiptoes) 
Yes No R 
Suggestive of dysfunctional voiding    
Needs to push in order to urinate, i.e. need to use abdominal 
muscles to strain to pass urine? 
Yes No R 
Suggestive of dysfunctional voiding    
Interrupted urinary stream, or several voids, one after another? Yes No R 
Suggestive of dysfunctional voiding    
History of urinary tract infection? Yes No R 
Often associated with underlying bladder dysfunction    
Illness and/or malformation? 
 Of kidneys and/or urinary tract 
 Of spinal cord 
Yes No R 
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Notes for physicians are given in gray text 
  
Signs and symptoms 
Presence 
Absence 
Consider 
Referral if positive (R) 
P A 
Comorbidity – factors that might predict therapy resistance  
Bowel movements – presence or history of the following? 
 Constipation ( 3 bowel movements/week) 
 Traces of feces in the underpants (fecal incontinence) – not 
due to insufficient wiping of the bottom? 
Yes No See annex 4 
May be treated in 
primary care 
May predict treatment resistance; resolution of constipation may 
resolve enuresis 
   
Psychological, behavioral or psychiatric problems? 
 Evidence of ADHD, ADD, autism, etc. 
Yes No R 
May predict treatment resistance    
History of motor and/or learning disabilities or delayed 
development 
Yes No R 
Delayed development may be suggestive of central nervous system 
pathology 
   
Drinking habits    
 Quantity and type of fluid intake? 
 Drinks more than one glass during the evening? 
 Drinks during the night? 
 
Yes 
Yes 
 
No 
No 
 
 
Water turnover in children is reported to be 1500 ml/m2 body surface 
area per day42 
Fluid intake in the evening (after the evening meal) should be 
minimized since increased fluid intake results in higher dieresis 
volumes during the night 
Fluid intake during the night should be avoided 
   
Exclude diabetes mellitus (dipstick test) 
Psychogenic polydipsia poses risk for water intoxication with 
desmopressin 
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Annex 4.  Rome III criteria for diagnosis of constipation  
At least two of the following criteria must be met for ≥2 months before diagnosis: 
(a) ≤2 defecations in the toilet per week 
(b) ≥1 episode of fecal incontinence per week 
(c) History of retentive posturing or excessive volitional stool retention 
(d) History of painful or hard bowel movements 
(e) Presence of a large fecal mass in the rectum 
(f) History of large diameter stools that may obstruct the toilet 
Patients should not have a diagnosis of irritable bowel syndrome 
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Annex 5. List of Abbreviation 
 
Abbreviation Full Word 
BOA Bladder Over Activity  
CNS Central Nervous System 
DSM IV Diagnostic and Statistical Manual Mental Disorders, fourth edition 
EA Enuresis Alarm 
ERIC Enuresis Resource and Information Centre 
ICCS International Children Continence Society  
ICI International Consultation on Incontinence 
LUT Lower Urinary Tract 
MNE Monosymptomatic Nocturnal Enuresis 
NE Nocturnal Enuresis  
NICE National Institute for Health and Care Excellence 
NMNE Nonmonosymptomatic Nocturnal Enuresis 
NP Nocturnal Polyuria  
PMNE Primary Monosymptomatic Nocturnal Enuresis 
PNE Primary Nocturnal Enuresis 
SNE Secondary Nocturnal Enuresis  
UNRWA United Nations Relief and Works Agency 
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Annex 6. The questionnaire used in the study 
Developing an Effective Service for Enuretic Children in UNRWA’s Health Centers 
from Northern WB 
Questionnaire Concerning Bed Wetting 
Research by Dr. Khaldoon Zaid   / Master’s Degree in Child Health 
Al Quds University /College of Graduate Studies 
Supervisors: Dr. Douglas Simkiss & Luma Tarazi 
The aim of this questionnaire is to find out any obstacles or difficulties that families 
faced when they are seeking help for their children. 
All data collected is subject of absolute secrecy and, it will be used only for scientific 
research purposes. 
Definition: Enuresis is defined as the repeated voiding of urine into the bed or clothes at least twice per 
week for at least three consecutive months in a child who is at least 5 years of age, with the absence of 
any congenital, acquired defects of the  
CNS or urinary tract (DMS-IV-TR) 
 
Name of the person who helped in filling this questionnaire…………………….Health Center…………… 
1. Your Current place of residence? Camp Village City 
2. What is the number of family members? (         )  Give number 
3. 
3.1 
3.2 
What is the educational level of the parents?  
University 
 
High school 
 
Less Father 
Mother University High school Less 
4. Economic situation of the family? Good Accepted Not accepted 
5. What is the date of birth of your child? 
6.1 
6.2 
What is the number of your children? (         ) Give number 
What is the order of the child between his siblings? (         ) Give number 
7. Does your child wet his or her clothes during the night or/and day? Night Day Both 
8 How long have you considered bedwetting a problem?  
9. How many times a week does your child wet the bed? Once Twice More 
01. Was your child able to have dry nights? Yes No 
10. If the answer to the previous question is yes, what is the time period 
for that? 
Less than one month More than one month  
12. Did you train your child for toilet? If Yes, at what age? Yes 
 
Age: 
No Sporadic 
13. How is the child's relationship with his family? Positive Tensioned Poor 
14. Was your child exposed to violence?    
15. Have there been other bedwetters in the family? Check all that apply Brothers/sist
ers 
Parents Uncles/aunts 
16. Are parents divorced or separated? Yes No 
17. The child lives with Mother Father  Both 
18. What is the child attitude towards his problem? unconcerned Timid & sad  Angry 
 
19. 
 
Do you or any family member do any of these things now to help 
treat the problem? 
Limit fluids 
 
Wake child up 
Punish failure 
 
Reward 
success 
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20. Is your child ever teased, bullied, or humiliated for being a 
bedwetter? 
Yes No Don’t 
Know 
 
 
20. 
 
 
 
From your child's point of view, please check all the reasons he or she 
wants to overcome bedwetting. Please circle the most important. 
Build self-esteem 
Feel more confident 
Avoid humiliation  
Share family experiences 
Be equal with other children 
Go to camp or sleepovers  
Be able to share a bed with their siblings  
Other 
22. Have you visited one of the UNRWA’s Health Centers? Yes No 
23. If the answer to question 22 is NO, please mention the reasons, 
difficulties and/or obstacles they have faced you or any other reasons, 
please mention it in detail 
 
1 
 
2 
 
3 
 
4 
 
23.
A 
If the answer to question 22 is YES, were you satisfied about the 
level of service provided and the results of treatment? 
Yes No 
23.
B 
If the treatment results and the level of service provided were 
dissatisfactory please indicate the reasons or obstacles from your 
point of view? 
1 
 
2 
 
3 
 
4 
 
23.
C 
23.
C1 
Did you stop attending our clinic?   
If Yes, please mention the reasons? 
Yes 
1 
 
2 
 
3 
 
4 
 
No 
24. Did you go to any other medical point for your child’s problem of 
bed wetting? 
Yes No 
25. What are your recommendations to overcome the difficulties and 
obstacles, as well as improve the service provided for the treatment of 
your child’s problem? 
1 
 
2 
 
3 
 
4 
 
 
